Author:
Safa Malek,Foon Kenneth A.,Oldham Robert K.
Reference116 articles.
1. Aboukameel A., Goustin A.S., Al-Khatib A., et al. Blood (ASH Meeting Abstracts) 2007;110: Abstract 2339.
2. Andrew AM, Pim MV, Perkins AC, Baldwin RW. Comparative imaging and biodistribution studies with an anti-CEA monoclonal antibody and its F(ab)2 and Fab fragments in mice with colon carcinoma xenografts. Eur J Nucl Med 1986;12:168–175.
3. Avner B, Avner BP, Gaydos B, et al. Characterization of a method using viable human target cells as the solid phase in a cell concentration fluorescence immunoassay (CCFIA) for screening of monoclonal antibodies and hybridoma supernatants. J Immunol Methods 1988;113:123–135.
4. Avner BP, Liao SK, Avner B, et al. Therapeutic murine monoclonal antibodies developed for individual cancer patients. J Biol Response Modif 1989;8(1):25–36.
5. Avner B, Swindell L, Sharp E, et al. Evaluation and clinical relevance of patient immune responses to intravenous therapy with murine monoclonal antibodies conjugated to adriamycin. Mol Biother 1991;3(1):14–21.